Mind Medicine Appoints Maria A. Oquendo To Scientific Advisory Board
Psychedelic-focused biotech company Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ) announced recently that it has tapped Maria A. Oquendo, M.D., Ph.D. to its scientific advisory board.
Oquendo is a Ruth Meltzer professor and chairman of Psychiatry at the University of Pennsylvania and psychiatrist-in-chief at the Hospital of the University of Pennsylvania.
She is also a past president of the American Psychiatric Association, the International Academy of Suicide Research and the American College of Neuropsychopharmacology. Oquendo is vice president of the board of the American Foundation for Suicide Prevention, vice president of the College of International Neuropsychopharmacology, and has served on the National Institute of Mental Health's advisory council.
"Our goal is to revolutionize mental health and addiction care, and we want to make effective treatments accessible to broad and diverse patient populations from across the globe," MindMed CEO Robert Barrow commented on the appointment. "Dr. Oquendo's extensive experience in psychiatry and pharmacology, including her work with high-risk patients, will be invaluable in progressing all of our research and development efforts."
Avant Brands Elects Directors
Cannabis producer Avant Brands Inc. (TSX: AVNT) (OTCQX: AVNTB) (FRA:1BUP) has elected each of the six nominees as directors during its annual general meeting of shareholders held on Friday, Nov. 5.
The following experts joined the board of the Kelowna, British Columbia-based company:
- Jurgen Schreiber
- Norton Singhavon
- Michael Blady
- Derek Sanders
- Ruairi Twomey
- Duane Lo
Delic Appoints KWC's CEO Kevin Nicholson New COO As Part Of Acquisition Deal
Kevin Nicholson, CEO of Ketamine Wellness Centers Arizona LLC, was named new chief operating officer for …